Health Care • Biotechnology: Laboratory Analytical Instruments
$0.79 ▼ -0.01
(-1.37%)
MKT CAP: $39.6M • VOL: 192.2K
52W L $1 52W H $5
ROARABLE / RQD
D • 47/100
PIOTROSKI
4 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$1
MEDIAN
$1
MEAN
$1
HIGH
$1
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE RPID TAPE
RPID // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $0.96 | $0.91 | 2025-02-14 | $0.72 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $1.00 | $0.93 | 2025-02-06 | $0.74 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $0.90 | $0.87 | 2025-01-29 | $0.76 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $0.81 | — | 2025-01-17 | $0.77 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $0.70 | $0.75 | 2025-01-09 | $0.70 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $0.94 | $0.82 | 2024-12-18 | $0.69 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $0.77 | $0.80 | 2024-12-04 | $0.73 | -4.3% | 48% | C |